SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-039464
Filing Date
2024-04-01
Accepted
2024-04-01 16:58:14
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acor-20231231.htm   iXBRL 10-K 3111440
2 EX-4.1 acor-ex4_1.htm EX-4.1 21451
3 EX-10.21 acor-ex10_21.htm EX-10.21 28786
4 EX-10.48 acor-ex10_48.htm EX-10.48 1011628
5 EX-10.49 acor-ex10_49.htm EX-10.49 381479
6 EX-10.50 acor-ex10_50.htm EX-10.50 1251660
7 EX-21 acor-ex21.htm EX-21 4149
8 EX-23 acor-ex23.htm EX-23 10132
9 EX-31.1 acor-ex31_1.htm EX-31.1 11915
10 EX-31.2 acor-ex31_2.htm EX-31.2 11935
11 EX-32.1 acor-ex32_1.htm EX-32.1 6483
12 EX-32.2 acor-ex32_2.htm EX-32.2 6497
13 GRAPHIC img224463671_0.jpg GRAPHIC 8006
  Complete submission text file 0000950170-24-039464.txt   18118565

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acor-20231231.xsd EX-101.SCH 2462069
118 EXTRACTED XBRL INSTANCE DOCUMENT acor-20231231_htm.xml XML 2626592
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31938 | Film No.: 24810535
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)